These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 4157374

  • 1. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
    Ristori C, Boccardo H, Borgoño JM, Greiber R, Heras E, Carrillo B, Solari G, Concha F.
    Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract] [Full Text] [Related]

  • 3. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E, Dincă L, Serbănescu R, Dinculescu M, Găleşanu M.
    Arch Roum Pathol Exp Microbiol; 1980 Jul; 39(1):31-40. PubMed ID: 6996640
    [No Abstract] [Full Text] [Related]

  • 4. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S, Morishima T, Nishikawa K, Hanada N, Rahman M, Terashima M, Kido S, Ueda S, Takahashi M.
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [Abstract] [Full Text] [Related]

  • 5. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA, Boĭchuk LM, Rykushin IuP, Smorodintsev AA.
    Tr Inst Im Pastera; 1979 Mar; 53():12-9. PubMed ID: 162456
    [No Abstract] [Full Text] [Related]

  • 6. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N, Ueda S, Tuchinda P, Sakuntanaga P, Sunthonsaratul A.
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract] [Full Text] [Related]

  • 7. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H, Ustaçelebi S.
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy evaluation of measles vaccine in fields].
    Liu M.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):292-4. PubMed ID: 1782660
    [Abstract] [Full Text] [Related]

  • 9. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984 Oct; 29(3):259-78. PubMed ID: 6438773
    [No Abstract] [Full Text] [Related]

  • 10. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P, Branciaroli A, Di Battista S, Di Filippo A, Di Pietro M, Calafiore P, Di Battista C.
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [Abstract] [Full Text] [Related]

  • 11. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE, Stokes J, Buynak EB, Leagus MB, Hilleman MR.
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract] [Full Text] [Related]

  • 12. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M, Cajal N, Cernescu C, Sorodoc Y, Aderca I, Tigăeru N, Suciu D, Manu S, Ferra A, Biberimoroianu S, Dobrescu A, Lucian M.
    Rev Roum Virol (1972); 1973 Apr; 10(1):8-17. PubMed ID: 4709858
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S, Yao Y, Zhou B, Zhang L, Yoksan S, Kelly K, Neuzil KM, Yaïch M, Jacobson J.
    Vaccine; 2008 Apr 24; 26(18):2234-41. PubMed ID: 18394765
    [Abstract] [Full Text] [Related]

  • 14. [Effectiveness of measles inoculations in the Hungarian People's Republic].
    Erdös L.
    Tr Inst Im Pastera; 1979 Apr 24; 53():19-25. PubMed ID: 262709
    [No Abstract] [Full Text] [Related]

  • 15. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL.
    Tr Inst Im Pastera; 1979 Apr 24; 53():75-8. PubMed ID: 162466
    [No Abstract] [Full Text] [Related]

  • 16. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF, Warburton MF.
    Med J Aust; 1974 May 18; 1(20):789-93. PubMed ID: 4853112
    [No Abstract] [Full Text] [Related]

  • 17. Wild measles virus strain: isolation and identification.
    Tikhonova NT, Mamaeva TA, Naumova MA, Leschinskaja EV, Volkov MV, Martynenko IM.
    Acta Virol; 1992 Dec 18; 36(6):557-66. PubMed ID: 1363990
    [Abstract] [Full Text] [Related]

  • 18. [Serological methods of detecting antibodies against the measles virus: use of the ELISA immunoenzyme technic].
    Rapicetta M, Proietti E, Morace G, Rozera C, Macchia T.
    Ann Ist Super Sanita; 1982 Dec 18; 18(3):525-8. PubMed ID: 7187839
    [No Abstract] [Full Text] [Related]

  • 19. Seroconversion following measles immunisation.
    Swami SS, Chandra S, Dudani IU.
    J Commun Dis; 1987 Jun 18; 19(2):141-5. PubMed ID: 3454353
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study of four live measles vaccines in Israel.
    Swartz T, Klingberg W, Nishmi M, Goldblum N, Gerichter C, Yofe Y, Cockburn WC.
    Bull World Health Organ; 1968 Jun 18; 39(2):285-92. PubMed ID: 5303410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.